It looks like the European Union could be on its way to saying goodbye to Monsanto’s most popular (and toxic) herbicide. Glyphosate, the star ingredient in Monsanto’s infamous Roundup, has been heavily scrutinized for its potential hazards and now, a bitter debate over re-licensing the noxious herbicide is brewing across the pond.

Over the summer, members of the European Parliament (MEPs) reached out to the U.S. District Court judge presiding over the Monsanto Roundup case, seeking to learn more about the science behind glyphosate. Specifically, the MEPs wanted to learn more about the validity behind the claims of glyphosate’s carcinogenic capacity. MEPs from a number of countries signed the request, including Bart Staes of Belgium, Heidi Hautala of Finland, Benedek Javor of Hungary and Michele Rivasi of France. Together, they asked U.S. District Court Judge Vince Chhabria to provide them with access to a number of related court documents and transcripts from the ongoing multi-district litigation against Monsanto taking place in Northern California. The EU has been struggling to come to a conclusive vote on glyphosate.

The MEPs are looking to gain assistance with unraveling the scientific evidence for and against the safety of glyphosate. Most notably, they want to better understand how World Health Organization’s International Agency for Research on Cancer and the European Food Safety Authority came to their “contradictory conclusions on the carcinogenicity of glyphosate.”

But not every country was interested in examining the evidence more closely; for some, it seems the determinations of these acclaimed organizations is more than enough. In July, an official from France’s environmental ministry revealed to the media that France would be voting against the re-authorization of glyphosate. The ministry official declared, “France will vote against the re-authorization of glyphosate due to the doubts that remain about its dangerousness.”

The European Union (EU) has failed to come to a conclusive vote on glyphosate on multiple occasions. The most recent vote, just a few months ago, also ended in a stalemate. The 28 member countries were at odds once again this summer; to approve authorization would grant Monsanto’s Roundup another 15 years on the European market — surely a decision no one wants to make lightly. Countries decidedly against renewing authorization for glyphosate, like France, prevented the toxic product from receiving a qualified majority of the vote.

For now, Monsanto’s Roundup has been given an 18-month extension, while officials continue to sift through the evidence and try to come to a decision. As BaumHedlandLaw.com explains, “With the vote to extend the license, experts from the member countries were able to set new requirements for the use of glyphosate herbicide, including scrutiny of preharvest use and minimizing glyphosate use in public spaces such as parks and playgrounds.”

The toxicity of glyphosate has been well-documented over the years — and while the EU’s action in this matter may be moving slowly, at least they are actually having a debate. Here in the U.S., any sort of legislation on Monsanto’s most profitable product seems to have been obscured by corruption and collusion — particularly with the help of the EPA.

Numerous reports have suggested that the federal agency has colluded with Monsanto to keep glyphosate on the market even in light of the product’s blatant and obvious hazards.

As Natural News writer Tracey Watson reports, it was just recently revealed that EPA agents actively sought to shut down an investigation of glyphosate by another federal agency, the Agency for Toxic Substances and Disease Registry (ATSDR). Back in 2015, the ATSDR was looking to conduct their own assessment of glyphosate, until the EPA stepped in. According to the EPA, there was no need for both agencies to examine the herbicide, and eventually the ATSDR put their report on hold, since the EPA was supposedly investigating the product as well. Watson reports that two years later, the EPA still hasn’t released their report. [Related: Keep up-to-date with the latest news on Roundup at Glyphosate.news.]

Sources for this article include:

BaumHedlundLaw.com

NaturalNews.com

Planterra, the United States-based “plant-based” meat arm of meat giant JBS, has announced a total shutdown later this year amid plummeting demand for fake meat.

The company issued a notice late last week to the Colorado Department of Labor and Employment that the brand’s corporate headquarters and manufacturing facility will be shut down completely by December 20. Some 121 jobs will be lost in the process.

Planterra, in case you are unfamiliar with the name, produces fake meat products under the name Ozo. It is a similar concept to Beyond Meat and Impossible Foods. (Related: Trends show that most people want nothing to do with fake meat.)

Like many other fake meat companies, Planterra launched its Ozo product line in early 2020, right around the time when the Wuhan coronavirus (Covid-19) scamdemic was launched.

It appears as though the globalists had big plans for fake meat after the world was forced to shut down for several years to fight the “virus.” Since that time, however, fake meat popularity has plummeted to dismal lows.

“The closure of Planterra is an ominous sign for the plant-based meat space in the U.S.,” reported Food Dive about the matter.

Why did Planterra announce permanent closure just a week after announcing a big expansion?

According to the Denver Business Journal, Planterra employees were sent home midweek last week in conjunction with the customary legal notice that was issued to the state.

Nikki Richardson, a JBS spokesperson, said in an emailed statement that the company is working to try to find new roles for Planterra employees at other JBS locations.

What is strange about the announcement is that just a week prior, Planterra had announced a foodservice expansion. Ozo’s Plant-Based “Bacon” was supposed to become available on breakfast sandwiches at Gregory’s Coffee and Veggie Grill.

In other words, Planterra said it was in the midst of a major expansion just a week before publicly announcing its permanent closure. Why would the company make this change so abruptly?

“We continue to believe in the potential of plant-based options for consumers and remain committed to the alternative protein market,” Richardson said about the decision.

“JBS will focus its efforts on its plant-based operations in Brazil and Europe, which continue to gain market share and expand their respective customer bases.”

On the surface, Planterra is said to have been performing well for JBS. The company was set to become the official plant-based protein of the Chicago Cubs, a major achievement.

In addition to fake bacon, the company also introduced fake “chicken.” It also unveiled a new R&D Innovation Center at its Colorado headquarters last August.

To go from all that to a complete shutdown came as a surprise to some. To others, it demonstrates the nature of corporate deception as JBS was apparently trying to keep its stock price stable amid internal problems with its fake meat division.

“Outward appearances … can be deceiving,” Food Dive says. “JBS is publicly traded, but the company is so massive globally, especially in its home country of Brazil, that it has not singled out Planterra’s performance in any recent earnings reports.”

“The business unit is lumped under JBS Beef North America, which saw a 4.6% decrease in year-over-year revenue in its most recent quarter. Other publicly traded meat companies have struggled with revenues recently because of costs, inflation and supply chain woes.”

For at least the past year, fake meat sales across the entire sector have been dwindling. During the 52-week period ending on September 4 of this year, IRI data cited by Bloomberg shows a 10.5 percent drop in retail fake meat sales.

The latest news about the collapse of the fake meat industry can be found at Frankenfood.news.

Sources for this article include:

FoodDive.com

NaturalNews.com